DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0007222 | Cardiovascular Diseases | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0524620 | Metabolic Syndrome X | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0852949 | Arteriopathic disease | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0028840 | Ocular Hypertension | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0086543 | Cataract | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0002871 | Anemia | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0917996 | Cerebral Aneurysm | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0153633 | Malignant neoplasm of brain | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C1861172 | Venous Thromboembolism | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0014544 | Epilepsy | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0036572 | Seizures | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C1384666 | hearing impairment | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C1306459 | Primary malignant neoplasm | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0243026 | Sepsis | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0020538 | Hypertensive disease | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C2239176 | Liver carcinoma | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0028754 | Obesity | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0085580 | Essential Hypertension | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0678222 | Breast Carcinoma | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0011849 | Diabetes Mellitus | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0027651 | Neoplasms | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0033578 | Prostatic Neoplasms | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0007766 | Intracranial Aneurysm | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024